Blackstone, Carlyle, KKR Eye $11 Billion Buyout

Apr 10 2013 | 10:28am ET

A trio of private equity giants are circling laboratory supplies and genetic testing company Life Technologies in what could be among the largest buyouts of the year.

The Blackstone Group, the Carlyle Group and Kohlberg Kravis Roberts, along with Singapore's sovereign wealth fund, are preparing an $11 billion bid for Life. The four were in talks late last night on terms, even after the deadline for bids passed. Should the private equity group manage to find the needed equity, Life would likely accept a bid after the deadline, according to Reuters.

The p.e. group will have to compete with a bid from Thermo Fisher Scientific, which submitted its offer yesterday.

The p.e. group as it exists is actually a merger of what could have been two competing consortia: Blackstone, Carlyle and Temasek Holdings had been working with TPG Capital, which has since dropped out, while KKR was working on a deal with other partners, who also backed out.


In Depth

Q&A: Old Hill's Stone On Private Debt, P2P And Credit Bubbles

Jun 6 2017 | 7:52pm ET

While institutional capital continues to flow into the broader private debt sector...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

AIMA: How The U.K.'s SMCR Will Affect U.S. Firms

Jun 20 2017 | 6:29pm ET

U.S. investment managers need to think seriously about how tough new U.K. conduct...

 

From the current issue of